ARTES offers a range of vac­cine pro­duc­ing cell lines and process­es for out-licens­ing and tech­nol­o­gy trans­fer. All list­ed cell lines are based on our safe and high yield expres­sion sys­tem Hansenu­la poly­mor­pha.

Avian Flupre-clin­i­cal PoC; based on METAVAX® VLP plat­form high­ly immuno­genic, adju­vant-free; cell line and process avail­able
Hepati­tis Blicensed world­wide; new tech­nol­ogy with improved yield; cell line and pcro­cess avail­able
(L1-6; -11; -16; -18;-31;-33;-45; -52; -58)
cell lines for the dif­fer­ent serotypes avail­able; process to be devel­oped; devel­op­ment time for the process approx. 18 months

To obtain a quote, please con­tact us at info(at) indi­cat­ing name of the vac­cine of inter­est to you. We will revert to you with a ded­i­cat­ed offer spec­i­fy­ing deliv­ery times and costs.